Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SGRL and BSE: 540737 (ISIN INE414Y01015).
It has a market capitalisation of ₹886 crore, a last close of ₹690.10 on 2026-10-19.
Valuation: a price-to-earnings ratio of 49.85x, a price-to-book ratio of 5.43x, a dividend yield of 0.0%.
Profitability: return on equity of 11.5%, return on capital employed of 15.2%, an operating margin of 32.0%.
Growth: sales growth of 6.6% a year over three years, net profit growth of 1.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.19x.
| Metric | Value |
|---|---|
| Market capitalisation | 886 |
| Last close | ₹690.10 |
| P/E (TTM) | 49.85x |
| P/B | 5.43x |
| Dividend yield | 0.0% |
| ROE (FY) | 11.5% |
| ROCE (FY) | 15.2% |
| Operating margin (TTM) | 32.0% |
| Sales growth, 3-year CAGR | 6.6% |
| Profit growth, 3-year CAGR | 1.5% |
| Debt / equity | 0.19x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means
